These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9666439)

  • 1. Peptide recognition mechanisms of eukaryotic signaling modules.
    Lee CH; Cowburn D; Kuriyan J
    Methods Mol Biol; 1998; 84():3-31. PubMed ID: 9666439
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Src Homology domains to other signaling modules: proposal of the 'protein recognition code'.
    Sudol M
    Oncogene; 1998 Sep; 17(11 Reviews):1469-74. PubMed ID: 9779993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src homology-2 domains: structure, mechanisms, and drug discovery.
    Sawyer TK
    Biopolymers; 1998; 47(3):243-61. PubMed ID: 9817027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphotyrosine-binding domains in signal transduction.
    Yaffe MB
    Nat Rev Mol Cell Biol; 2002 Mar; 3(3):177-86. PubMed ID: 11994738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structural biology of SH2 and SH3].
    Inagaki F
    Tanpakushitsu Kakusan Koso; 1999 Mar; 44(4 Suppl):355-67. PubMed ID: 10203990
    [No Abstract]   [Full Text] [Related]  

  • 8. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 domains: role, structure and implications for molecular medicine.
    Waksman G; Kumaran S; Lubman O
    Expert Rev Mol Med; 2004 Jan; 6(3):1-18. PubMed ID: 14987415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2 and PTB domains in tyrosine kinase signaling.
    Schlessinger J; Lemmon MA
    Sci STKE; 2003 Jul; 2003(191):RE12. PubMed ID: 12865499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity and promiscuity in the interaction network mediated by protein recognition modules.
    Castagnoli L; Costantini A; Dall'Armi C; Gonfloni S; Montecchi-Palazzi L; Panni S; Paoluzi S; Santonico E; Cesareni G
    FEBS Lett; 2004 Jun; 567(1):74-9. PubMed ID: 15165896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering new aspects of protein interactions through analysis of specificity landscapes in peptide recognition domains.
    Gfeller D
    FEBS Lett; 2012 Aug; 586(17):2764-72. PubMed ID: 22710167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grasp a pTyr-peptide by its SOCS.
    Hirano T; Murakami M
    Dev Cell; 2006 May; 10(5):542-4. PubMed ID: 16678769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide modulators of protein-protein interactions in intracellular signaling.
    Souroujon MC; Mochly-Rosen D
    Nat Biotechnol; 1998 Oct; 16(10):919-24. PubMed ID: 9788346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surprisingly flexible PTB domain.
    Siegal G
    Nat Struct Biol; 1999 Jan; 6(1):7-10. PubMed ID: 9886281
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
    Hou T; McLaughlin W; Lu B; Chen K; Wang W
    J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.
    Calderwood DA; Fujioka Y; de Pereda JM; García-Alvarez B; Nakamoto T; Margolis B; McGlade CJ; Liddington RC; Ginsberg MH
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2272-7. PubMed ID: 12606711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphotyrosyl mimetics in the development of signal transduction inhibitors.
    Burke TR; Lee K
    Acc Chem Res; 2003 Jun; 36(6):426-33. PubMed ID: 12809529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.